Skip to Content
The 192nd General Court of the Commonwealth of Massachusetts

Bill H.4865 190th (2017 - 2018)

An Act relative to certain genetically targeted drug coverage for Duchenne Muscular Dystrophy

Substituted by the House, on motion of Mr. Speliotis of Danvers, for a bill with the same title (House, No. 3644). July 31, 2018.

Bill Information

Theodore C. Speliotis
Referred to Senate Committee on Ways and Means

Bill History

Displaying 5 actions for Bill H.4865
Date Branch Action
7/31/2018 House Substituted for H3644
7/31/2018 House Ordered to a third reading
7/31/2018 House Passed to be engrossed
8/6/2018 Senate Read; and referred to the committee on Senate Ways and Means
1/1/2019 Senate No further action taken

The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.